FDAFDA · Food and drugs·Recall number D-1289-2014
LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 11.25 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3779-03, UPC 3 00743 77903 5.
Published May 7, 2014 · Recall initiated: March 10, 2014
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LUPRON DEPOT-PED
- Manufacturer
- AbbVie Inc
- Distributor
- Nationwide and Puerto Rico
- UPC
- 300743779035
- Lot
- Lot #:1013566, Exp 12/08/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.